Literature DB >> 60909

The biological origin of antibody diversity.

A R Williamson.   

Abstract

Antibody diversity has a compelling fascination for many scientists and over the years speculations have sometimes seemed more numerous than facts. Now the structural basis of antibody specificity is well defined. Amino acid sequences and recently three-dimensional structures of various immunoglobulins provide the most solid basis for discussing the origin of diversity. The novel pattern of variable (V) and Constant (C) regions of amino acid sequence has been resolved further to show the functional pattern of variability. Inheritance of separate V and C genes is accepted, but attempts to define more than one gene coding for each V region are considered here to be unnecessary. The pattern of variability is still best understood in terms of mutation and the presence or absence of various selective pressures. The major area of debate still hinges around the extent to which mutation and selection operate during evolution or somatically. Sequence data have now been generally interpreted to require multiple V genes carried in the germ line. A few individual VH genes have been mapped in close linkage to CH genes in the mouse. The apparent existence of three VH alleles in rabbits was a strong argument against multiple V genes. Now the three phenotypes have been shown to be due to alleles controlling the expression of three sets of VH genes all present on the same chromosome. That V-gene expression requires rejoining of V and C genes at the DNA level is now almost certain. Models for the joining process can draw on the precedents of transposable genetic elements, which are widespread in Nature. The total extent of antibody diversity remains a philosophical point. Estimates of the number of antibody molecules required for observed diversity are reduced by two recently documented proposals. Each antibody combining site apparently has many (estimated at 100) different specificities and most combinations of VH and VL regions probably form a viable site. A given combining site can be defined by its pattern of shared specificities. Several specific antibody repertoires have been measured and the size in each case is consistent with the stringency with which the specificity is selected. Repertoire size appears to be under genetic control, but there are problems in viewing the genotype through the veil of clonal selection. Molecular hybridization has been used recently in an attempt to count V and C genes directly. C genes are seen in DNA having nonreiterated sequences, as formal genetics predicts. Each V-region probe hybridizes at a similar rate to C-region probes. Interpretation of this result depends on the extent to which one V-region probe will reveal nonhomologous V genes. Previous estimates that many cross-hybridizing genes should have been seen if present are possibly exaggerated. It is argued here that the data are compatible with a germ-line gene for each probe studied. Maximum estimates for the number of germ-line genes are sufficient to account for antibody diversity...

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60909     DOI: 10.1146/annurev.bi.45.070176.002343

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  10 in total

Review 1.  Lymphocytes. 1. Function. Genetic restrictions in the immune response.

Authors:  A J McMichael
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Genetic variation in mouse salivary amylase rate of synthesis.

Authors:  J P Hjorth
Journal:  Biochem Genet       Date:  1979-08       Impact factor: 1.890

Review 3.  Roy Cameron lecture. Control of antibody formation: certain uncertainties.

Authors:  A R Williamson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

4.  An experimental approach to enumerate the genes coding for immunoglobulin variable-regions.

Authors:  E P Zeelon; A L Bothwell; F Kantor; I Schechter
Journal:  Nucleic Acids Res       Date:  1981-08-11       Impact factor: 16.971

5.  Expression of IgD may use both DNA rearrangement and RNA splicing mechanisms.

Authors:  K W Moore; J Rogers; T Hunkapiller; P Early; C Nottenburg; I Weissman; H Bazin; R Wall; L E Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  Isolation and characterization of germ line DNA from mouse sperm.

Authors:  R Shiurba; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

7.  Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon.

Authors:  F Vlaspolder; T Harmsen; D van Veenendaal; C A Kraaijeveld; H Snippe
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

8.  Modeling the asymmetric evolution of a mouse and rat-specific microRNA gene cluster intron 10 of the Sfmbt2 gene.

Authors:  Stefan Lehnert; Vladimir Kapitonov; Pushpike J Thilakarathne; Frans C Schuit
Journal:  BMC Genomics       Date:  2011-05-23       Impact factor: 3.969

9.  Crystal structure of a human single domain antibody dimer formed through V(H)-V(H) non-covalent interactions.

Authors:  Toya Nath Baral; Shi-Yu Chao; Shenghua Li; Jamshid Tanha; Mehdi Arbabi-Ghahroudi; Jianbing Zhang; Shuying Wang
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

10.  Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domain.

Authors:  Sebastian Fenn; Christian B Schiller; Julia J Griese; Harald Duerr; Sabine Imhof-Jung; Christian Gassner; Joerg Moelleken; Joerg Thomas Regula; Wolfgang Schaefer; Markus Thomas; Christian Klein; Karl-Peter Hopfner; Hubert Kettenberger
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.